Evidence map›Paper›PMID 33064743›Full record

ArticlePLoS pathogens2020

Qualitative Differences Between the IFNα subtypes and IFNβ Influence Chronic Mucosal HIV-1 Pathogenesis.

Kejun Guo, Guannan Shen, Jon Kibbie, Tania Gonzalez, Stephanie M Dillon, Harry A Smith, Emily H Cooper, Kerry Lavender, Kim J Hasenkrug, Kathrin Sutter and 5 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. An atlas of protein phosphorylation dynamics during interferon signaling.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Review
  5. Review
  6. Selenoprotein S: A versatile disordered protein.Archives of biochemistry and biophysics · 2022
    Review
  7. Article
  8. Interferon resistance of emerging SARS-CoV-2 variants.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  9. Review
  10. Specialized interferon action in COVID-19.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  11. Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  12. Superior antiviral activity of IFNβ in genital HSV-1 infection.Frontiers in cellular and infection microbiology · 2022
    Article
  13. Article
  14. Article
  15. Interferon Resistance of Emerging SARS-CoV-2 Variants.bioRxiv : the preprint server for biology · 2021
    Article
  16. Article
  17. Article
  18. Gut Innate Immunity and HIV Pathogenesis.Current HIV/AIDS reports · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Kejun GuoDepartment of Medicine, University of Colorado School of Medicine, Aurora, CO, United States of America.ORCID 0000-0003-1121-7603
Guannan ShenCenter for Innovative Design and Analysis, Department of Biostatistics and Informatics, University of Colorado School of Medicine, Aurora, CO, United States of America.ORCID 0000-0002-8708-001X
Jon KibbieDepartment of Medicine, University of Colorado School of Medicine, Aurora, CO, United States of America.
Tania GonzalezDepartment of Medicine, University of Colorado School of Medicine, Aurora, CO, United States of America.
Stephanie M DillonDepartment of Medicine, University of Colorado School of Medicine, Aurora, CO, United States of America.
Harry A SmithCenter for Innovative Design and Analysis, Department of Biostatistics and Informatics, University of Colorado School of Medicine, Aurora, CO, United States of America.ORCID 0000-0001-8750-8461
Emily H CooperCenter for Innovative Design and Analysis, Department of Biostatistics and Informatics, University of Colorado School of Medicine, Aurora, CO, United States of America.ORCID 0000-0001-9340-8336
Kerry LavenderDepartment of Biochemistry, Microbiology and Immunology, University of Saskatchewan, Canada.ORCID 0000-0002-5329-4546
Kim J HasenkrugRocky Mountain Laboratories, National Institutes of Allergy and Infectious Diseases, Hamilton, MT, United States of America.ORCID 0000-0001-8523-4911
Kathrin SutterInstitute for Virology, University Hospital Essen, University of Duisberg-Essen, Essen, Germany.ORCID 0000-0001-6397-6551
Ulf DittmerInstitute for Virology, University Hospital Essen, University of Duisberg-Essen, Essen, Germany.
Miranda KroehlCenter for Innovative Design and Analysis, Department of Biostatistics and Informatics, University of Colorado School of Medicine, Aurora, CO, United States of America.ORCID 0000-0002-3840-3660
Katerina KechrisCenter for Innovative Design and Analysis, Department of Biostatistics and Informatics, University of Colorado School of Medicine, Aurora, CO, United States of America.ORCID 0000-0002-3725-5459
Cara C WilsonDepartment of Medicine, University of Colorado School of Medicine, Aurora, CO, United States of America.ORCID 0000-0002-3955-2326
Mario L SantiagoDepartment of Medicine, University of Colorado School of Medicine, Aurora, CO, United States of America.ORCID 0000-0001-7792-2706
University of Colorado Denver · USEssen University Hospital · DENational Institute of Allergy and Infectious Diseases · USUniversity of Saskatchewan · CA

Funding

HIV Infection in Humanized MiceZIAAI001141 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI HASENKRUG, KIM · 2011 to 2019
$4.2M
Role of Type I IFNs in Mucosal HIV-1 Immunity and PathogenesisR01AI134220 · NIAID · UNIVERSITY OF COLORADO DENVER · PI SANTIAGO, MARIO LUIS, WILSON, CARA C. · 2017 to 2021
$2.7M
Intramural NIH HHS ZIA AI001141NIAID NIH HHS R01 AI134220
6 · The paper itself

Abstract

The Type I Interferons (IFN-Is) are innate antiviral cytokines that include 12 different IFNα subtypes and IFNβ that signal through the IFN-I receptor (IFNAR), inducing hundreds of IFN-stimulated genes (ISGs) that comprise the 'interferome'. Quantitative differences in IFNAR binding correlate with antiviral activity, but whether IFN-Is exhibit qualitative differences remains controversial. Moreover, the IFN-I response is protective during acute HIV-1 infection, but likely pathogenic during the chronic stages. To gain a deeper understanding of the IFN-I response, we compared the interferomes of IFNα subtypes dominantly-expressed in HIV-1-exposed plasmacytoid dendritic cells (1, 2, 5, 8 and 14) and IFNβ in the earliest cellular targets of HIV-1 infection. Primary gut CD4 T cells from 3 donors were treated for 18 hours ex vivo with individual IFN-Is normalized for IFNAR signaling strength. Of 1,969 IFN-regulated genes, 246 'core ISGs' were induced by all IFN-Is tested. However, many IFN-regulated genes were not shared between the IFNα subtypes despite similar induction of canonical antiviral ISGs such as ISG15, RSAD2 and MX1, formally demonstrating qualitative differences between the IFNα subtypes. Notably, IFNβ induced a broader interferome than the individual IFNα subtypes. Since IFNβ, and not IFNα, is upregulated during chronic HIV-1 infection in the gut, we compared core ISGs and IFNβ-specific ISGs from colon pinch biopsies of HIV-1-uninfected (n = 13) versus age- and gender-matched, antiretroviral-therapy naïve persons with HIV-1 (PWH; n = 19). Core ISGs linked to inflammation, T cell activation and immune exhaustion were elevated in PWH, positively correlated with plasma lipopolysaccharide (LPS) levels and gut IFNβ levels, and negatively correlated with gut CD4 T cell frequencies. In sharp contrast, IFNβ-specific ISGs linked to protein translation and anti-inflammatory responses were significantly downregulated in PWH, negatively correlated with gut IFNβ and LPS, and positively correlated with plasma IL6 and gut CD4 T cell frequencies. Our findings reveal qualitative differences in interferome induction by diverse IFN-Is and suggest potential mechanisms for how IFNβ may drive HIV-1 pathogenesis in the gut.

Indexed as

AdultAntiviral AgentsCase-Control StudiesDendritic CellsFemaleGastrointestinal TractGene Expression ProfilingHIV-1HIV InfectionsHumansInterferon-alphaInterferon-betaMaleMiddle AgedYoung AdultAntiviral AgentsInterferon-alphaInterferon-beta

Identifiers

PMID33064743
PMCPMC7592919
OpenAlexW3093319329

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.